Table 4.
Reclassification of the study population using histopathologic criteria (3): cases with two criteria among four criteria in relation to recurrence
| Combination of criteria | Patients with recurrence (n = 28) |
Patients without recurrence (n = 139) |
p-value | ||
|---|---|---|---|---|---|
| Present | Absent | Present | Absent | ||
| K3 and I | 3 (10.7) | 25 (89.3) | 9 (6.5) | 130 (93.5) | .43 |
| K3 and p20 | 2 (7.1) | 26 (92.9) | 0 | 139 (100) | < .01* |
| K3 and M2 | 1 (3.6) | 27 (96.4) | 2 (1.4) | 137 (98.6) | .44 |
| I and p20 | 1 (3.6) | 27 (96.4) | 2 (1.4) | 137 (98.6) | .44 |
| I and M2 | 1 (3.6) | 27 (96.4) | 1 (.7) | 138 (99.3) | .21 |
| p20 and M2 | 1 (3.6) | 27 (96.4) | 0 | 139 (100) | .03* |
K3, Ki-67 LI > 3%; I, invasion; p20, p53 immunoreactivity ≥ 20%; M2, mitosis ≥ 2/10HPF.
*
Significant difference (p < .05).